Biotech stocks advanced in the week ended Nov. 13 amid a vaccine news flow-induced rally that also lifted the broader market.The week started with positive tidings from Pfizer Inc. (NYSE: PFE) and its German partner BioNTech SE – ADR (NASDAQ: BNTX), which reported positive interim Phase 3 data for their jointly developed mRNA vaccine against the COVID-19 coronavirus.An update from rival vaccine developer Moderna Inc (NASDAQ: MRNA) on reaching the mandated number of cases for its first interim analysis also generated optimism.Five Prime Therapeutics Inc (NASDAQ: FPRX) rallied over 300% during the week, with the upside primarily due to …read more
Source:: Yahoo Finance
